Large Granular Lymphocyte Leukemia and Precapillary Pulmonary Hypertension
Authors:
Abstract
No abstract availableFunding Information
- GlaxoSmithKline Australia
- Bayer
- Merck
- United Therapeutics Corporation
This publication has 17 references indexed in Scilit:
- Occlusive Lung Arterial Lesions in Endothelial-Targeted, Fas-Induced Apoptosis Transgenic MiceAmerican Journal of Respiratory Cell and Molecular Biology, 2015
- 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertensionEuropean Heart Journal, 2015
- Chemotherapy-Induced Pulmonary HypertensionThe American Journal of Pathology, 2015
- Low-dose methotrexate in PAH related to T-cell large granular lymphocyte leukaemiaEuropean Respiratory Journal, 2012
- How I treat LGL leukemiaBlood, 2011
- A critical role for DAP10 and DAP12 in CD8+ T cell–mediated tissue damage in large granular lymphocyte leukemiaBlood, 2009
- Clinical improvement by farnesyltransferase inhibition in NK large granular lymphocyte leukemia associated with imbalanced NK receptor signalingBlood, 2008
- Human NK Cells Lyse Organ-Specific Endothelial Cells: Analysis of Adhesion and Cytotoxic MechanismsThe Journal of Immunology, 2005
- Clinicopathological features of aggressive large granular lymphocyte leukaemia resemble Fas ligand transgenic miceBritish Journal of Haematology, 2000
- Primary Pulmonary Hypertension in a Patient With CD8/T-cell Large Granulocyte Leukemia*Chest, 1997